Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases

Mingming Sun(The University of Texas Medical Branch at Galveston), Wei Wu(The University of Texas Medical Branch at Galveston), Zhanju Liu(Shanghai Tenth People's Hospital), Yingzi Cong(The University of Texas Medical Branch at Galveston)
Journal of Gastroenterology
July 23, 2016
10.1007/s00535-016-1242-9
Cited by 1,057Open Access
Full Text

Abstract

Related Papers

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Yukihiro Furusawa, Yuuki Obata, Shinji Fukuda et al.|Nature|2013|5.3k
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
Nagendra Singh, Ashish Gurav, Sathish Sivaprakasam et al.|Immunity|2014|2.3k
Short-chain fatty acids in control of body weight and insulin sensitivity
Emanuel E. Canfora, Johan W. E. Jocken, Ellen E. Blaak|Nature Reviews Endocrinology|2015|2.2k
The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
Pamela V. Chang, Liming Hao, Stefan Offermanns et al.|Proceedings of the National Academy of Sciences|2014|2.1k
Phylogenetic distribution of three pathways for propionate production within the human gut microbiota
Nicole Reichardt, Sylvia H. Duncan, Pauline Young et al.|The ISME Journal|2014|1.2k